Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 15, 2014
- Accepted in final form January 14, 2015
- First Published March 25, 2015.
Article Versions
- Previous version (March 25, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Marco Duering, MD*,
- Ruthger Righart, PhD*,
- Frank Arne Wollenweber, MD,
- Vera Zietemann, PhD,
- Benno Gesierich, PhD and
- Martin Dichgans, MD
- Marco Duering, MD*,
NONE
NONE
travel expenses for lectures from the United Leukodystrophy Foundation, the European Stroke Conference and Kenes International.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) German Center for Neurodegenerative Diseases (DZNE), VaD/MixD, PI, 2011-2014
NONE
(1) Vascular Dementia Research Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Ruthger Righart, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Frank Arne Wollenweber, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vera Zietemann, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Benno Gesierich, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martin Dichgans, MD
NONE
NONE
(1) Bayer Vital, travel expenses and honoraria for lectures, (2) Boehringer Ingelheim Pharma, travel expenses and honoraria for lectures, (3) Heel, travel expenses and honoraria for lectures, (4) Bristol-Meyer Squibb, travel expenses and honoraria for lectures, (5) Lundeck, travel expenses and honoraria for lectures, (6) Sanofi- Aventis, travel expenses and honoraria for lectures, (7) Shire, travel expenses and honoraria for lectures, (8) German Research Foundation (DFG), research support, (9) Vascular Dementia Research Foundation, research support, (10) Corona Foundation, research support, (11) Jackst?dt Foundation, research support.
(1) Stroke the International Journal of Stroke, editor, (2) Cerebrovascular diseases, editorial board member, (3) Journal of Neurochemistry, editor
NONE
NONE
NONE
(1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol-Meyer Squibb, (4) Heel
NONE
NONE
NONE
NONE
(1) Wellcometrust, 03/08 following, (2) European Union (EU FP 7), investigator, 10/13-09/16, (3) German Federal Ministry of Education and Research (BMBF), investigator, 12/13-11/16, (4) European Union (EU FP 6), investigator, 03/12-02/15
NONE
(1) Vascular Dementia Research Foundation, (2) Corona Foundation, (3) Jackst?dt Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the Institute for Stroke and Dementia Research (M.D., R.R., F.A.W., V.Z., B.G., M.D.), Klinikum der Universität München, Ludwig-Maximilians University, Munich; German Center for Neurodegenerative Diseases (DZNE, Munich) (R.R., M.D.), Munich; and Munich Cluster for Systems Neurology (SyNergy) (M.D.), Munich, Germany. R.R. is currently with the Department of Neurology, Technische Universität München, Munich, Germany.
- Correspondence to Dr. Dichgans: martin.dichgans{at}med.uni-muenchen.de
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.